Prelude Therapeutics Inc

• WILMINGTON, DE How do I update this listing?

Prelude Therapeutics is based out of Wilmington. Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth. Prelude Therapeutics serves patients worldwide. The firm last filed a Form D notice of exempt offering of securities on 2020-08-28. The notice included securities offered of Equity

Contact Info

prelude therapeutics inc
200 POWDER MILL ROAD
WILMINGTON DE 19803
Business Phone: (302) 547-3768

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold	Total Remaining
2020-08-28	D	BIOTECHNOLOGY	Equity	49,999,969	49,999,969	0
2019-06-17	D	BIOTECHNOLOGY	Equity	59,999,998	29,999,999	29,999,999
2018-08-17	D/A	BIOTECHNOLOGY	Equity	29,999,998	29,999,998	0
2017-10-20	D	BIOTECHNOLOGY	Equity	12,000,000	12,000,000	0
2016-07-11	D	BIOTECHNOLOGY	Equity	5,000,000	5,000,000	0

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
KRISHNA VADDI	subscription required	EXECUTIVE OFFICER DIRECTOR
PAUL FRIEDMAN	subscription required	DIRECTOR
DAVID BONITA	subscription required	DIRECTOR
KELVIN NEU	subscription required	DIRECTOR
JUAN LUENGO	subscription required	EXECUTIVE OFFICER
PEGGY SCHERLE	subscription required	EXECUTIVE OFFICER
DAVID MAURO	subscription required	EXECUTIVE OFFICER
VICTOR SANDOR	subscription required	DIRECTOR
MARDI C. DIER	subscription required	DIRECTOR
ANDREW COMBS	subscription required	EXECUTIVE OFFICER
BRIAN PIPER	subscription required	EXECUTIVE OFFICER
CHRISTOPHER PIERCE	subscription required	EXECUTIVE OFFICER
DEBORAH MOROSINI	subscription required	EXECUTIVE OFFICER